These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 27665287)

  • 81. Palivizumab Exposure and the Risk of Autoimmune Disease: A Cross-National Cohort Study.
    Haerskjold A; Linder M; Henriksen L; Thomsen SF; Kieler H; Ravn H; Stensballe LG
    Paediatr Drugs; 2016 Dec; 18(6):435-441. PubMed ID: 27665287
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Palivizumab Exposure and the Risk of Atopic Dermatitis, Asthma and Allergic Rhinoconjunctivitis: A Cross-National, Population-Based Cohort Study.
    Haerskjold A; Stokholm L; Linder M; Thomsen SF; Bergman G; Berglind IA; Kieler H; Ravn H; Stensballe LG
    Paediatr Drugs; 2017 Apr; 19(2):155-164. PubMed ID: 28188494
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Product review on the monoclonal antibody palivizumab for prevention of respiratory syncytial virus infection.
    Resch B
    Hum Vaccin Immunother; 2017 Sep; 13(9):2138-2149. PubMed ID: 28605249
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Palivizumab prophylaxis, respiratory syncytial virus and subsequent development of asthma.
    Igde M; Kabasakal H; Ozturk O; Karatekin G; Aygun C
    Minerva Pediatr; 2018 Jun; 70(3):252-259. PubMed ID: 29795072
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Cost effectiveness of palivizumab for respiratory syncytial virus prophylaxis in high-risk children: a UK analysis.
    Nuijten MJ; Wittenberg W; Lebmeier M
    Pharmacoeconomics; 2007; 25(1):55-71. PubMed ID: 17192118
    [TBL] [Abstract][Full Text] [Related]  

  • 86. The Danish National Prescription Registry in studies of a biological pharmaceutical: palivizumab - validation against two external data sources.
    Haerskjold A; Henriksen L; Way S; Malham M; Hallas J; Pedersen L; Stensballe LG
    Clin Epidemiol; 2015; 7():305-12. PubMed ID: 26056490
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Use of palivizumab is underestimated in the Swedish Prescribed Drug Register - implications for register-based drug studies.
    Linder M; Byström C; Kieler H; Bergman G; Haerskjold A
    Clin Epidemiol; 2015; 7():45-51. PubMed ID: 25565893
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Bias--is it a problem, and what should we do?
    Dohoo IR
    Prev Vet Med; 2014 Feb; 113(3):331-7. PubMed ID: 24176138
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Propensity score methods for confounding control in nonexperimental research.
    Brookhart MA; Wyss R; Layton JB; Stürmer T
    Circ Cardiovasc Qual Outcomes; 2013 Sep; 6(5):604-11. PubMed ID: 24021692
    [No Abstract]   [Full Text] [Related]  

  • 90. Pediatric and adult celiac disease: similarities and differences.
    Poddar U
    Indian J Gastroenterol; 2013 Sep; 32(5):283-8. PubMed ID: 23715643
    [TBL] [Abstract][Full Text] [Related]  

  • 91. External review and validation of the Swedish national inpatient register.
    Ludvigsson JF; Andersson E; Ekbom A; Feychting M; Kim JL; Reuterwall C; Heurgren M; Olausson PO
    BMC Public Health; 2011 Jun; 11():450. PubMed ID: 21658213
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Immunotoxicity and immunogenicity of biopharmaceuticals: design concepts and safety assessment.
    Bhogal N
    Curr Drug Saf; 2010 Oct; 5(4):293-307. PubMed ID: 20615176
    [TBL] [Abstract][Full Text] [Related]  

  • 93. The safety and side effects of monoclonal antibodies.
    Hansel TT; Kropshofer H; Singer T; Mitchell JA; George AJ
    Nat Rev Drug Discov; 2010 Apr; 9(4):325-38. PubMed ID: 20305665
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Immunotoxicity of monoclonal antibodies.
    Descotes J
    MAbs; 2009; 1(2):104-11. PubMed ID: 20061816
    [TBL] [Abstract][Full Text] [Related]  

  • 95.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 96.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 97.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.